Arnold P. Kling

This profile gathers the share dealings of Arnold P. Kling across 5 companies, led by Protalex Inc, Adma Biologics, Inc. and Appgate, Inc. Over a trading history stretching from 6 March 2006 to 28 February 2018, the count stands at 8 filings.

Both buying and selling appear: 1 purchase worth €18.2M, against 1 sale. The totals exclude 1 filing filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2018: 1 purchase and no sales on the market.

The newest entry dates from 2 March 2018: an open-market purchase of €18.2M, in Protalex Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.